Story by the Herald
Scientists have taken a major step forward in understanding how to reduce the severity of multiple sclerosis, it was claimed yesterday.
A team at Bristol University carried out tests on mice and then on human brain tissue and found that the neuropeptide “galanin” was resistant to the MS-like disease, experimental autoimmune encephalomyelitis (EAE).
Professor David Wynick, who works on the function of galanin in the relief of neuropathic pain, initiated the project and worked with Professors David Wraith and Neil Scolding on the research.
Mr Wraith, who is working on a vaccine for the treatment of multiple sclerosis, said: “The results were really remarkable, rarely do you see such a dramatic effect as this.
“Mice with high levels of galanin just didn’t develop any signs of disease. We have a lot more to do to figure out how this works but the results are extremely promising.”
A spokeswoman for the university said that although the results are “very encouraging” there is still a large amount of work to be done before a drug can be developed and it could be at least 10 years before being released on the market.
She said the research team are now expected to seek the “substantial” funding needed to advance their findings.
Meanwhile, a cheap drug widely used to reduce blood pressure could help combat MS, new research suggests.
Last week The Herald reported how US scientists had developed a cheap drug, Lisinopril, which reduced blood pressure and prevented paralysis in mice which were made to suffer MS symptoms.
The MS Society reacted to the experiments by stating that drugs which dampen down an overactive immune system have been shown to be of “some benefit” to sufferers of the condition.
A pill, Cladribine, may soon be available to UK patients after it was hailed by the society as a major step forward in the effective treatment on the condition. It was involved in promising trials in the US treating relapsing-remitting MS, the most common form of the disease.
Scotland has the highest prevalence of MS in the world and 10,500 people have the condition. In June, schoolboy Ryan McLaughlin, 14, from Drumchapel, Glasgow, whose former athlete mother was stricken by MS made an impassioned plea for help to halt the disease as he took his own one-man campaign to the Scottish Parliament.
He dressed as William Wallace as he led children from two schools down the Royal Mile chanting and singing.
He called on Holyrood’s petitions committee to push for pregnant women and young children in Scotland to be given vitamin D supplements to help prevent the disease that has crippled his mother, former Tae Kwon Do champion Kirsten, 34.
Scientists believe extra doses could prevent up to 80% of cases of MS, for which there is no cure.







